首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nature biomedical engineering

缩写:NAT BIOMED ENG

ISSN:2157-846X

e-ISSN:2157-846X

IF/分区:26.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1496
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Koichi Sasaki,Vipul Bhatia,Yuta Asano et al. Koichi Sasaki et al.
Immunosuppressive microenvironments, the lack of immune infiltration, and antigen heterogeneity pose challenges for chimaeric antigen receptor (CAR)-T cell therapies applied to solid tumours. Previously, CAR-T cells were armoured with immun...
Yannik Kaiser,Christopher S Garris,Eliana Marinari et al. Yannik Kaiser et al.
Glioblastoma is a highly aggressive brain tumour with a high risk of recurrence after surgery, even when combined with chemotherapy and radiotherapy. A major barrier to lasting treatment is the tumour's immunosuppressive environment, which ...
Ning Wang,Zichao Luo,Chao Liu et al. Ning Wang et al.
Photodynamic therapy-induced immunogenic cell death has the potential to generate autologous cancer vaccines. However, the innate or evolved genetic tolerance of tumours limits the efficacy of this approach. Here we report the development o...
Kellen Chen,Michelle Griffin,Dominic Henn et al. Kellen Chen et al.
In response to injury, a variety of different cells are recruited to sites of injury to facilitate healing. Recent studies have examined the importance of the heterogeneity of tissue resident fibroblasts and mechanical signalling pathways i...
Ángel Ramírez-Fernández,Alexander J Dimitri,Fang Chen et al. Ángel Ramírez-Fernández et al.
Immune-based cell therapy offers a promising approach to cancer treatment. While autologous chimeric antigen receptor (CAR) T cells have shown success, production is time-consuming, costly and patient specific. Gamma-delta (γδ) T cells ar...